“Integra Lifesciences has entered into an agreement to acquire TEI Biosciences and TEI Medical in a transaction valued at $312 million,” according to an article from FDANews.com. “The TEI buyout expands Integra’s portfolio of surgery and regenerative wound care products, Integra said Sunday.” Click here for more details: http://www.fdanews.com/articles/171892-integra-to-buy-tei-biosciences-and-tei-medical